Today we have released our Annual Report for the 12 months ending 30 June 2023 (FY23).
In our Annual Report we provide an overview of Rua’s pivotal year, which has seen us focus on developing unique genetics, executing our export-led strategy and achieving our first international sales. You can read more about the benefits of our capital-light operating model, and our preparations for our next stage of growth.
The Annual Report is attached and available now on the Rua website www.ruabio.com/annual-report. Those who have requested it will receive a hard copy in the post in due course
For more information, please visit www.ruabio.com or contact:
Chief Executive Officer
+64 (21) 445 154
Top gainer of the day was Comvita, which added 25.7%, taking its share price to $2.25.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details